PT - JOURNAL ARTICLE AU - Owen W Tomlinson AU - Zoe L Saynor AU - Daniel Stevens AU - Don Urquhart AU - Craig A Williams TI - The impact of COVID-19 upon the delivery of exercise services within cystic fibrosis clinics in the United Kingdom AID - 10.1101/2021.04.12.21255205 DP - 2021 Jan 01 TA - medRxiv PG - 2021.04.12.21255205 4099 - http://medrxiv.org/content/early/2021/04/16/2021.04.12.21255205.short 4100 - http://medrxiv.org/content/early/2021/04/16/2021.04.12.21255205.full AB - The COVID-19 pandemic has resulted in unprecedent change to clinical practice. As the impact upon delivery of exercise services for people with cystic fibrosis (CF) in the UK was unknown, this was characterised via a national survey. In total, 31 CF centres participated. Principal findings included a significant reduction in exercise testing, and widespread adaptation to deliver exercise training using telehealth methods. Promisingly, 71% stated that they would continue to use virtual methods of engaging patients in future practice. This does, however, highlight a need to develop sustainable and more standardised telehealth services further to manage patients moving forwards.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis survey was undertaken as part of the Youth Active Unlimited Strategic Research Centre (SRC) funded by the Cystic Fibrosis Trust (SRC#008). CA Williams is the Chief Investigator of this SRC.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the University of Exeter Sport and Health Sciences Ethics Committee (200708-A-01).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData not available due to ethical restrictions.CFcystic fibrosisMDTmulti-disciplinary teamNHSNational Health ServicePAphysical activityUKUnited Kingdom